Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Make a Passover gift and support Jewish journalism. DONATE NOW
Fast Forward

AIPAC Urges Congress to Approve U.S. Intervention in Syria

WASHINGTON – The influential pro-Israel lobby group AIPAC urged U.S. lawmakers on Tuesday to approve a resolution allowing the Obama administration to retaliate for chemical weapons use in Syria.

“AIPAC urges Congress to grant the president the authority he has requested to protect America’s national security interests and dissuade the Syrian regime’s further use of unconventional weapons,” AIPAC said in a letter to members of Congress obtained by Reuters.

“Support the president’s effort to protect American security interests,” read the banner headline on the letter, the first time the lobbying group has weighed in on the Syria crisis.

“The civilized world cannot tolerate the use of these barbaric weapons, particularly against an innocent civilian population including hundreds of children,” the group said.

President Barack Obama has asked Congress for authorization for the use of military force against the government of Syrian President Bashar al-Assad after a two-year civil war that has killed 100,000 people and an apparent chemical weapons attack the killed more than 1,000 civilians.

“America’s allies and adversaries are closely watching the outcome of this momentous vote,” AIPAC said in the letter signed by its president, Michael Kassen, and chief executive, Howard Kohr.

Members of Obama’s administration have been urging lawmakers to back intervention, often making the case that failure to act against Syria would endanger Israel by allowing instability on its borders and emboldening Iran, which western powers believe is developing nuclear weapons.

“This is a critical moment when America must also send a forceful message of resolve to Iran and Hezbollah – both of whom have provided direct and extensive military support to Assad,” AIPAC said in its statement.

This is a moment of great uncertainty. Here’s what you can do about it.

We hope you appreciated this article. Before you go, we’d like to ask you to please support the Forward’s independent Jewish news this Passover. All donations are being matched by the Forward Board - up to $100,000.

This is a moment of great uncertainty for the news media, for the Jewish people, and for our sacred democracy. It is a time of confusion and declining trust in public institutions. An era in which we need humans to report facts, conduct investigations that hold power to account, tell stories that matter and share honest discourse on all that divides us.

With no paywall or subscriptions, the Forward is entirely supported by readers like you. Every dollar you give this Passover is invested in the future of the Forward — and telling the American Jewish story fully and fairly.

The Forward doesn’t rely on funding from institutions like governments or your local Jewish federation. There are thousands of readers like you who give us $18 or $36 or $100 each month or year.

Support our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines.
You must comply with the following:

  • Credit the Forward
  • Retain our pixel
  • Preserve our canonical link in Google search
  • Add a noindex tag in Google search

See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.